US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 96.640
  • +1.540+1.62%
Trading Nov 29 10:46 ET
6.14BMarket Cap-46239P/E (TTM)

About Blueprint Medicines Company

Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.

Company Profile

SymbolBPMC
Company NameBlueprint Medicines
Listing DateApr 30, 2015
Issue Price18.00
Founded2008
CEOMs. Kathryn Haviland
MarketNASDAQ
Employees655
Fiscal Year Ends12-31
Address45 Sidney Street
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02139
Phone1-617-374-7580
Websitehttp://www.blueprintmedicines.com

Company Executives

  • Name
  • Position
  • Salary
  • Kathryn Haviland
  • Director, President and Chief Executive Officer
  • 6.43M
  • Dr. Percy H. Carter, M.B.A.,PhD
  • Chief Scientific Officer
  • 2.30M
  • Tracey L. McCain, Esq.
  • Chief Legal and Compliance Officer
  • --
  • Dr. Christopher K. Murray, PhD
  • Chief Technical Operations and Quality Officer
  • --
  • Christina Rossi, M.B.A.
  • Chief Operating Officer
  • 2.81M
  • Michael Landsittel, M.B.A.
  • Chief Financial Officer
  • 2.19M
  • Dr. Becker Hewes, M.D.
  • Chief Medical Officer
  • --
  • Debra Durso-Bumpus
  • Chief People Officer
  • --
  • Dr. Philina Lee, PhD
  • Chief Commercial Officer
  • --
  • Ariel Hurley
  • Senior Vice President, Finance and Principal Accounting Officer
  • --
  • Dr. Fouad Namouni, M.D.
  • President, Research and Development
  • 2.80M
  • Jeffrey W. Albers, J.D.
  • Chairman of the Board
  • 526.08K
  • Alexis A. Borisy, A.M.
  • Director
  • 397.33K
  • Daniella Beckman
  • Independent Director
  • 422.33K
  • Lonnel Coats
  • Independent Director
  • 419.33K
  • Dr. Nicholas Lydon, F.R.S.,PhD
  • Independent Director
  • 417.33K
  • Dr. John Tsai, M.D.
  • Independent Director
  • 769.80K
  • Habib Joseph Dable
  • Independent Director
  • 412.33K
  • Dr. Mark Alan Goldberg, M.D.
  • Independent Director
  • 419.33K
  • Dr. Lynn Seely,M.D.
  • Lead Independent Director
  • 452.33K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Investment Theme Cancer Research
Cancer Research
Intraday-0.03%